Home » Stocks » NEPH

Nephros, Inc. (NEPH)

Stock Price: $8.80 USD 0.00 (0.00%)
Updated Aug 2, 2021 4:00 PM EDT - Market open
Market Cap 84.31M
Revenue (ttm) 8.77M
Net Income (ttm) -4.21M
Shares Out 10.09M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day August 2
Last Price $8.80
Previous Close $8.80
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 8.30 - 9.00
Day's Volume 14
52-Week Range 5.08 - 11.67

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 days ago - Zacks Investment Research

Strategic Acquisition Accelerates Pathogen Detection Product Development

3 weeks ago - GlobeNewsWire

SOUTH ORANGE, NJ, July 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medic...

3 weeks ago - GlobeNewsWire

Nephros Inc (NASDAQ: NEPH) has announced preliminary results and expects Q2 sales of approximately $2.2 million, representing a Y/Y increase of 40%  "Revenue growth seems to be returning to pre-pandemic...

3 weeks ago - Benzinga

Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase; Submits HDF Product to FDA for 510(k) Clearance

3 weeks ago - GlobeNewsWire

Nephros Inc. (NEPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our...

1 month ago - Zacks Investment Research

Nephros Inc. (NEPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through o...

2 months ago - Zacks Investment Research

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 57.14% and 1.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Net Revenue of $2.7 Million; Highest First Quarter in Company History

2 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company, today announced that it will file its first quarter financial ...

3 months ago - GlobeNewsWire

Anticipates Net Revenue of $2.7 Million; Highest First Quarter in Company History

3 months ago - GlobeNewsWire

SOUTH ORANGE, N.J., March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the me...

4 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, March 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --  Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the m...

4 months ago - GlobeNewsWire

Nephros Inc. (NEPH) delivered earnings and revenue surprises of 33.33% and 1.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Nephros (NASDAQ:NEPH) were flat after the company reported Q4 results. Quarterly Results Earnings per share fell 300.00% over the past year to ($0.08), which beat the estimate of ($0.11).

5 months ago - Benzinga

Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third Quarter Full Year Revenue $8.6 million, Down 17% Against Prior Year

5 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the med...

5 months ago - GlobeNewsWire

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

SOUTH ORANGE, NJ, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the med...

5 months ago - GlobeNewsWire

Anticipates $2.3 Million Revenue in Fourth Quarter, $8.5 Million in Full-Year; Quarterly Revenue Grew 9% Sequentially Over Third Quarter; Full Year Revenue Declined 17%

6 months ago - GlobeNewsWire

HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021

6 months ago - GlobeNewsWire

HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021

6 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and p...

8 months ago - GlobeNewsWire

Finance Veteran Strengthens Management Team; Quarter-over-Quarter Net Revenue up 34%; Year-over-Year down 31%

8 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 29, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire  -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and...

9 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a commercial-stage company that develops and sells high performance wat...

9 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --  Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

9 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and...

9 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, Oct. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and p...

9 months ago - GlobeNewsWire

  Daron Evans to Remain Senior Science Advisor and CEO of Specialty Renal Products

11 months ago - GlobeNewsWire

Nephros, Inc. (NEPH) CEO Daron Evans on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

SOUTH ORANGE, NJ, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Net Revenue down 32% due to COVID-19 Interruptions

11 months ago - GlobeNewsWire

SOUTH ORANGE, NJ, July 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells water purification products and pathogen detect...

1 year ago - GlobeNewsWire

  Nephros SequaPath™, a new microbial screening system, used to evaluate 88 building water samples across four US geographic regions

1 year ago - GlobeNewsWire

SOUTH ORANGE, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification produ...

1 year ago - GlobeNewsWire

Anticipates $1.6 Million Net Revenues

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, June 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and ...

1 year ago - GlobeNewsWire

SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification produ...

1 year ago - GlobeNewsWire

Executives to Present Business Overviews

1 year ago - GlobeNewsWire

Product Revenue up 43% over Q1 2019

1 year ago - GlobeNewsWire

Nephros has been struggling lately, but the selling pressure may be coming to an end soon.

1 year ago - Zacks Investment Research

Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019

1 year ago - GlobeNewsWire

Medical Device Veteran Hired to Drive FDA Clearance and Market Launch

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

Nephros, Inc. (NEPH) CEO Daron Evans on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

SOUTH ORANGE, NJ, Feb. 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (Nasdaq: NEPH) (“Nephros” or the “Company”), a  commercial-stage company that develops and sells high performance w...

1 year ago - GlobeNewsWire

SOUTH ORANGE, NJ, Jan. 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products an...

1 year ago - GlobeNewsWire

Anticipates $10.3 Million Full-Year Revenue, Approximately 82% Growth Over 2018; Fourth Quarter Year-Over-Year Revenue Growth Approximately 99%

1 year ago - GlobeNewsWire

While most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Other stocks mentioned: CERS, NOG, SYRS, ZNGA
1 year ago - 24/7 Wall Street

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Sep 21, 2004
Stock Exchange
NASDAQ
Ticker Symbol
NEPH
Full Company Profile

Financial Performance

In 2020, Nephros's revenue was $8.56 million, a decrease of -17.16% compared to the previous year's $10.33 million. Losses were -$4.77 million, 39.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Nephros stock is "Buy." The 12-month stock price forecast is 13.83, which is an increase of 57.16% from the latest price.

Price Target
$13.83
(57.16% upside)
Analyst Consensus: Buy